
Editor's Note: This article originally appeared in the September 2025 print edition of Today's Medical Developments under the headline “Auditory brainstem implant shows promise for hearing loss”.
A study co-led by Mass General Brigham researchers points to a promising new type of auditory brainstem implant (ABI) that could benefit people who are deaf due to neurofibromatosis type 2 (NF2) and other severe inner ear abnormalities preventing them from receiving cochlear implants. With further tests and trials, researchers hope it will provide a more effective treatment alternative than what is currently used.
In the new research, published in Nature Biomedical Engineering, scientists at Mass Eye and Ear, a member of the Mass General Brigham healthcare system, collaborated with scientists at the École Polytechnique Fédérale de Lausanne (EPFL) in Geneva, Switzerland, to report on a new class of soft, flexible ABIs designed to address the limitations of those currently used. These implants bypass damaged auditory structures and directly stimulate the brainstem’s sound-processing region to restore auditory function.
The new ABI was born out of a decade-long collaboration between Mass Eye and Ear and EPFL scientists. It features an elastic, multilayer construct including ultra-thin platinum electrodes and silicone, a novel design allowing it to conform closely to the brainstem’s curved surface.
Conventional ABIs sometimes used in patients with NF2 rely on stiff electrodes struggling to conform to the curved surface of the cochlear nucleus in the brainstem. That limits their effectiveness to modest benefits, typically providing only basic sound awareness to aid lip reading. The design can also cause side effects such as discomfort discouraging long-term use.
The novel, soft electrode design was developed using advanced thin-film processing techniques, allowing for closer contact and more precise stimulation. In preclinical tests conducted in Switzerland, two macaques received the implants and underwent several months of behavioral testing. Results showed the animals could consistently distinguish between different patterns of stimulation – which indicated high-resolution auditory perception, a promising sign for eventual human use.
“While cochlear implants are life-changing for many, there remains a group of patients for whom current technology falls short,” says study co-senior author Daniel J. Lee, M.D., FACS, Ansin Foundation Chair in Otolaryngology at Mass Eye and Ear. “Our research lays the groundwork for a future auditory brainstem implant that could improve hearing outcomes and reduce side effects in patients who are deaf and do not benefit from the cochlear implant.”
Mass General Brigham
https://www.massgeneralbrigham.org
École Polytechnique Fédérale de Lausanne
https://www.epfl.ch/en
Explore the September 2025 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology
- Xact Metal launches the XM200G µHD metal printer
- #77 Manufacturing Matters - Supply Chain - Smoothing Out or Something Else? with Lisa Anderson